Paul Ginocchio
CIK 1826036 · CHIEF FINANCIAL OFFICER · last filed 2024-10-04
Paul Ginocchio is a CHIEF FINANCIAL OFFICER who has filed 16 SEC Form 4 insider transactions across 1 company since 2021. Across all open-market trades the lifetime net is +$280.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
16
$280.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Augmedix, Inc. (AUGX) Delisted | CHIEF FINANCIAL OFFICER | 135,795 | $2.35 | $319.1K | $280.7K | 10 | 2024-08-19 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-04 | — | Disp (D) | −135,795 | -$319.1K | |
| 2024-08-19 | Augmedix, Inc. (AUGX) Delisted | Mixed | +3,899 | -$5.3K | EDGAR |
| 2024-05-17 | Augmedix, Inc. (AUGX) Delisted | Mixed | +3,896 | -$2.8K | EDGAR |
| 2024-02-27 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-27 | Augmedix, Inc. (AUGX) Delisted | Buy (P) | +10,000 | $48.5K | EDGAR |
| 2023-02-22 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-15 | Augmedix, Inc. (AUGX) Delisted | Buy (P) | +18,000 | $21.6K | EDGAR |
| 2022-05-27 | Augmedix, Inc. (AUGX) Delisted | Buy (P) | +18,000 | $35.9K | EDGAR |
| 2022-03-11 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-23 | Augmedix, Inc. (AUGX) Delisted | Buy (P) | +14,000 | $41.4K | EDGAR |